LEP and metabolic syndrome: Hyperglycemia, insulin resistance, elevated insulin, and insulin-like growth factor-1 (IGF-1) levels, inflammatory cytokines, dyslipidemia, increased leptin, and decreased adiponectin have all been attributed to the increased risk of cancer in patients with diabetes [37].